134 related articles for article (PubMed ID: 38511246)
21. The combined effect of permeation enhancement and proteolysis inhibition on the systemic exposure of orally administrated peptides: Salcaprozate sodium, soybean trypsin inhibitor, and teriparatide study in pigs.
Burshtein G; Itin C; Tang JCY; Galitzer H; Fraser WD; Schwartz P
Int J Pharm X; 2021 Dec; 3():100097. PubMed ID: 34704013
[TBL] [Abstract][Full Text] [Related]
22. Development and evaluation of C10 and SNAC erodible tablets for gastric delivery of a GIP/GLP1 peptide in monkeys.
Tran H; Dogra M; Huang S; Aihara E; ElSayed M; Aburub A
Int J Pharm; 2024 Jan; 650():123680. PubMed ID: 38070657
[TBL] [Abstract][Full Text] [Related]
23. Nasal absorption enhancement of protein drugs independent to their chemical properties in the presence of hyaluronic acid modified with tetraglycine-L-octaarginine.
Tomono T; Yagi H; Ukawa M; Ishizaki S; Miwa T; Nonomura M; Igi R; Kumagai H; Miyata K; Tobita E; Kobayashi H; Sakuma S
Eur J Pharm Biopharm; 2020 Sep; 154():186-194. PubMed ID: 32681963
[TBL] [Abstract][Full Text] [Related]
24. Gastrointestinal absorption enhancement of insulin by administration of enteric microspheres and SNAC to rats.
Qi R; Ping QN
J Microencapsul; 2004 Feb; 21(1):37-45. PubMed ID: 14718184
[TBL] [Abstract][Full Text] [Related]
25. [Studies on gastrointestinal absorption enhancement effect and mechanism of sodium N-[8-(2-hydroxybenzyl)amino] caprylate to insulin solution].
Qi R; Ping QN; Zhao W
Yao Xue Xue Bao; 2003 Dec; 38(12):953-6. PubMed ID: 15040094
[TBL] [Abstract][Full Text] [Related]
26. Oral heparin administration with a novel drug delivery agent (SNAC) in healthy volunteers and patients undergoing elective total hip arthroplasty.
Berkowitz SD; Marder VJ; Kosutic G; Baughman RA
J Thromb Haemost; 2003 Sep; 1(9):1914-9. PubMed ID: 12941031
[TBL] [Abstract][Full Text] [Related]
27. Investigation of the enhancing mechanism of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate effect on the intestinal permeability of polar molecules utilizing a voltage clamp method.
Hess S; Rotshild V; Hoffman A
Eur J Pharm Sci; 2005 Jun; 25(2-3):307-12. PubMed ID: 15911227
[TBL] [Abstract][Full Text] [Related]
28. Intestinal absorptivity-increasing effects of sodium N-[8-(2-hydroxybenzoyl)amino]-caprylate on food-derived bioactive peptide.
Xu Y; Amakye WK; Xiao G; Liu X; Ren J; Wang M
Food Chem; 2023 Feb; 401():134059. PubMed ID: 36095999
[TBL] [Abstract][Full Text] [Related]
29. Orally administered heparin for preventing deep venous thrombosis.
Gonze MD; Manord JD; Leone-Bay A; Baughman RA; Garrard CL; Sternbergh WC; Money SR
Am J Surg; 1998 Aug; 176(2):176-8. PubMed ID: 9737627
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and pharmacodynamics of oral heparin solid dosage form in healthy human subjects.
Mousa SA; Zhang F; Aljada A; Chaturvedi S; Takieddin M; Zhang H; Chi L; Castelli MC; Friedman K; Goldberg MM; Linhardt RJ
J Clin Pharmacol; 2007 Dec; 47(12):1508-20. PubMed ID: 18048572
[TBL] [Abstract][Full Text] [Related]
31. Absence of QTc Prolongation with Sodium N-(8-[2-Hydroxybenzoyl] Amino) Caprylate (SNAC), an Absorption Enhancer Co-Formulated with the GLP-1 Analogue Semaglutide for Oral Administration.
Granhall C; Bækdal TA; Breitschaft A; Søndergaard FL; Anderson TW; Thomsen M
Diabetes Ther; 2021 Sep; 12(9):2599-2610. PubMed ID: 34319564
[TBL] [Abstract][Full Text] [Related]
32. Orally administered unfractionated heparin with carrier agent is therapeutic for deep venous thrombosis.
Gonze MD; Salartash K; Sternbergh WC; Baughman RA; Leone-Bay A; Money SR
Circulation; 2000 Jun; 101(22):2658-61. PubMed ID: 10840020
[TBL] [Abstract][Full Text] [Related]
33. A novel per-oral insulin formulation: proof of concept study in non-diabetic subjects.
Kidron M; Dinh S; Menachem Y; Abbas R; Variano B; Goldberg M; Arbit E; Bar-On H
Diabet Med; 2004 Apr; 21(4):354-7. PubMed ID: 15049938
[TBL] [Abstract][Full Text] [Related]
34. Pancreatic kininogenase improves erectile function in streptozotocin-induced type 2 diabetic rats with erectile dysfunction.
Chen GT; Yang BB; Chen JH; Zhang Z; Zhu LL; Jiang HS; Yu W; Chen Y; Dai YT
Asian J Androl; 2018; 20(5):448-453. PubMed ID: 29676291
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic Study of Enteric-Coated Sustained-Release Aspirin Tablets in Healthy Chinese Participants.
Cong D; Qi W; Liu X; Xu X; Dong L; Xue W; Li K
Drug Des Devel Ther; 2023; 17():2421-2429. PubMed ID: 37614377
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of salmon calcitonin (sCT) enteric-coated capsule for enhanced absorption and GI tolerability in rats.
Wu L; Zhang G; Lu Q; Sun Q; Wang M; Li N; Gao Z; Sun Y; Li T; Han D; Yu X; Wang L; Sun W; Zhao D; Wu Y; Lu Y; Chen X
Drug Dev Ind Pharm; 2010 Mar; 36(3):362-70. PubMed ID: 19719396
[TBL] [Abstract][Full Text] [Related]
37. Effect of Oral Semaglutide on the Pharmacokinetics of Lisinopril, Warfarin, Digoxin, and Metformin in Healthy Subjects.
Bækdal TA; Borregaard J; Hansen CW; Thomsen M; Anderson TW
Clin Pharmacokinet; 2019 Sep; 58(9):1193-1203. PubMed ID: 30945118
[TBL] [Abstract][Full Text] [Related]
38. Safety and Pharmacokinetics of Single and Multiple Ascending Doses of the Novel Oral Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 Diabetes.
Granhall C; Donsmark M; Blicher TM; Golor G; Søndergaard FL; Thomsen M; Bækdal TA
Clin Pharmacokinet; 2019 Jun; 58(6):781-791. PubMed ID: 30565096
[TBL] [Abstract][Full Text] [Related]
39. Phase I clinical study to select a novel oral formulation for ibandronate containing the excipient sodium N-[8-(2-hydroxybenzoyl) amino] caprylate (SNAC).
Bittner B; McIntyre C; Tian H; Tang K; Shah N; Phuapradit W; Ahmed H; Chokshi H; Infeld M; Fotaki N; Ma H; Portron A; Jordan P; Schmidt J
Pharmazie; 2012 Mar; 67(3):233-41. PubMed ID: 22530305
[TBL] [Abstract][Full Text] [Related]
40. Identify super quality markers from prototype-based pharmacokinetic markers of Tangzhiqing tablet (TZQ) based on in vitro dissolution/ permeation and in vivo absorption correlations.
Li Z; Liu J; Li Y; Du X; Li Y; Wang R; Lv C; He X; Wang B; Huang Y; Zhang D
Phytomedicine; 2018 Jun; 45():59-67. PubMed ID: 29685365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
